Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity
| Autor: | Ali Peirovifar, Haleh Mostafidi, Karim Sadeghi, Manizheh Mostafa Gharehbaghi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2012 |
| Předmět: |
Male
360 retinopexy lens diameter ocular trauma pupil Growth Insulin-like growth factor-binding protein phenylephrine hydrochloride Pathogenesis silicone oil tamponade lcsh:Ophthalmology disaccommodation retinopathy of prematurity lens thickness lens wet weight tissue plasminogen activator biology Obstetrics lens dry weight Gestational age Retinopathy of prematurity human adult Insulin-like growth factor-1 Gestation Apgar score Original Article Female Infant Premature subretinal hemorrhage medicine.medical_specialty Accommodation velocity Birth weight vitrectomy Enzyme-Linked Immunosorbent Assay Gestational Age polypoidal choroidal vasculopathy mydriasis encirclage Silicone oil removal medicine Humans submacular hemorrhage business.industry Age-related macular degeneration insulin-like growth factor binding protein-3 oil emulsification Infant Newborn medicine.disease Infant newborn eye diseases retinal macroaneurysm Ophthalmology Insulin-Like Growth Factor Binding Protein 3 lcsh:RE1-994 chorodial neovascularization biology.protein business |
| Zdroj: | Indian Journal of Ophthalmology, Vol 60, Iss 6, Pp 527-530 (2012) Indian Journal of Ophthalmology |
| ISSN: | 1998-3689 0301-4738 |
| Popis: | Background: Retinopathy of prematurity (ROP) is the main cause of visual impairment in preterm newborn infants. Objective: This study was conducted to determine whether insulin-like growth factor binding protein -3 (IGFBP-3) is associated with proliferative ROP and has a role in pathogenesis of the disease in premature infants. Materials and Methods: A total of 71 preterm infants born at or before 32 weeks of gestation participated in this study. Studied patients consisted of 41 neonates without vaso-proliferative findings of ROP as the control group and 30 preterm infants with evidence of severe ROP in follow up eye examination as the case group. Blood samples obtained from these infants 6-8 weeks after birth and blood levels of IGFBP-3 were measured using enzyme-linked immunosorbent assay (ELISA). Results: The mean gestation age and birth weight of the studied patients were 28.2±1.6 weeks and 1120.7±197 gram in the case group and 28.4±1.6 weeks and 1189.4±454 gram in the control group (P=0.25 and P=0.44 respectively). The infants in the case group had significantly lower Apgar score at first and 5 min after birth. Insulin-like growth factor binding protein -3 (IGFBP-3) was significantly lower in the patients with proliferative ROP than the patients without ROP [592.5±472.9 vs. 995.5±422.2 ng/ml (P=0.009)]. Using a cut-off point 770.45 ng/ml for the plasma IGFBP-3, we obtained a sensitivity of 65.9% and a specificity of 66.7% in the preterm infants with vasoproliferative ROP. Conclusion: Our data demonstrated that the blood levels IGFBP-3 was significantly lower in the patients with ROP and it is suspected that IGFBP-3 deficiency in the premature infants may have a pathogenetic role in proliferative ROP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|